PHILIP GILLY: Open Payments
NPI 1609849868 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 49 payments from 9 companies in 2025. Trend: 2023 $436 · 2024 $551 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 15 | $233 |
| Indivior Inc. | 16 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $162 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| ABBVIE INC. | 4 | $93 |
| Alkermes, Inc. | 2 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Orexo US, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
Products named: BRIXADI, SUBLOCADE, CAPLYTA, ABILIFY MAINTENA, MAVYRET, VIVITROL, INGREZZA, Zubsolv.
Industry payments across MI — which companies pay providers there.
